解开并发症和多药对艾滋病毒感染者的认知功能和身体虚弱的影响
Henry Ukachukwu Michael1,2, Marie-Josée Brouillette3,4,5, Robyn Tamblyn1,6
1Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Journal of acquired immune deficiency syndromes (1999)
|September 9, 2024
概括
抗胆固醇和镇静药物显著影响艾滋病毒感染者的认知能力,认知缺陷和身体虚弱. 减少这些负担可能有助于管理这一群体的认知障碍和虚弱.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 携带艾滋病毒的老年人经常经历复杂的健康挑战,包括并发症和多药.
- 在这个人群中,认知障碍和身体虚弱是很重要的问题.
- 药物负担,特别是抗胆固醇和镇静效应在加剧这些问题的作用需要进一步调查.
研究的目的:
- 调查并发症,多药和抗胆固醇/镇静剂负担之间的相互关系.
- 确定这些因素如何影响艾滋病毒感染者的认知能力,认知缺陷 (PCD) 和身体虚弱.
主要方法:
- 使用结构方程建模 (SEM) 进行横截面研究.
- 来自加拿大824名艾滋病毒感染的老年人的数据 (正面大脑健康现在研究).
- SEM将观察到的变量 (并发症,多药性,抗胆固醇/镇静剂负担) 与认知能力和潜在结构 (身体虚弱,PCD) 联系在一起,并根据共变量进行调整.
主要成果:
- 抗胆固醇负担直接和负面影响认知能力.
- 抗胆固醇和镇静剂负担调解了共发病和多药对PCD和身体虚弱的影响.
- 镇静剂负担与PCD直接相关,通过PCD间接与脆弱相关.
结论:
- 抗胆固醇和镇静剂药物负担是将多药和并发症与艾滋病毒感染者的身体虚弱和PCD联系起来的途径.
- 旨在减少抗胆固醇和镇静药物的使用的干预措施可能是有益的.
- 这种减少可以帮助预防和管理艾滋病毒感染的老年人认知障碍和虚弱.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
Cognitive Development During Adulthood
68
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
68
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452


